Treatment and long-term outcomes in pituitary carcinoma: a cohort study

F Santos-Pinheiro, M Penas-Prado… - European journal of …, 2019 - academic.oup.com
Background Pituitary carcinoma (PC) is an aggressive neuroendocrine tumor diagnosed
when a pituitary adenoma (PA) becomes metastatic. PCs are typically resistant to therapy …
被引用次数：37 相关文章

Treatment and long-term outcomes in pituitary carcinoma: a cohort study.

F Santos-Pinheiro, M Penas-Prado… - European Journal of …, 2019 - europepmc.org
Background Pituitary carcinoma (PC) is an aggressive neuroendocrine tumor diagnosed
when a pituitary adenoma (PA) becomes metastatic. PCs are typically resistant to therapy …

Treatment and long-term outcomes in pituitary carcinoma: a cohort study

F Santos-Pinheiro, M Penas-Prado… - European journal …, 2019 - pubmed.ncbi.nlm.nih.gov
Background Pituitary carcinoma (PC) is an aggressive neuroendocrine tumor diagnosed
when a pituitary adenoma (PA) becomes metastatic. PCs are typically resistant to therapy …

Treatment and long-term outcomes in pituitary carcinoma: A cohort study

F Santos-Pinheiro… - European journal …, 2019 - mdanderson.elsevierpure.com
Background: Pituitary carcinoma (PC) is an aggressive neuroendocrine tumor diagnosed
when a pituitary adenoma (PA) becomes metastatic. PCs are typically resistant to therapy …

Treatment and long-term outcomes in pituitary carcinoma: a cohort study.

F Santos-Pinheiro, M Penas-Prado… - European Journal …, 2019 - search.ebscohost.com
Background: Pituitary carcinoma (PC) is an aggressive neuroendocrine tumor diagnosed
when a pituitary adenoma (PA) becomes metastatic. PCs are typically resistant to therapy …